These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 27951466)

  • 1. Clinical validation of a novel diagnostic HIV-2 total nucleic acid qualitative assay using the Abbott m2000 platform: Implications for complementary HIV-2 nucleic acid testing for the CDC 4th generation HIV diagnostic testing algorithm.
    Chang M; Wong AJ; Raugi DN; Smith RA; Seilie AM; Ortega JP; Bogusz KM; Sall F; Ba S; Seydi M; Gottlieb GS; Coombs RW
    J Clin Virol; 2017 Jan; 86():56-61. PubMed ID: 27951466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nucleic acid testing by public health referral laboratories for public health laboratories using the U.S. HIV diagnostic testing algorithm.
    Wesolowski LG; Wroblewski K; Bennett SB; Parker MM; Hagan C; Ethridge SF; Rhodes J; Sullivan TJ; Ignacio-Hernando I; Werner BG; Owen SM
    J Clin Virol; 2015 Apr; 65():6-10. PubMed ID: 25766979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance of an alternative laboratory-based algorithm for diagnosis of HIV infection utilizing a third generation immunoassay, a rapid HIV-1/HIV-2 differentiation test and a DNA or RNA-based nucleic acid amplification test in persons with established HIV-1 infection and blood donors.
    Wesolowski LG; Delaney KP; Hart C; Dawson C; Owen SM; Candal D; Meyer WA; Ethridge SF; Branson BM
    J Clin Virol; 2011 Dec; 52 Suppl 1():S45-9. PubMed ID: 21995934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of supplemental testing with the Multispot HIV-1/HIV-2 Rapid Test and APTIMA HIV-1 RNA Qualitative Assay to resolve specimens with indeterminate or negative HIV-1 Western blots.
    Linley L; Ethridge SF; Oraka E; Owen SM; Wesolowski LG; Wroblewski K; Landgraf KM; Parker MM; Brinson M; Branson BM
    J Clin Virol; 2013 Dec; 58 Suppl 1():e108-12. PubMed ID: 24342469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance of the new HIV-1/2 diagnostic algorithm in Florida's public health testing population: a review of the first five months of utilization.
    Bennett B; Neumann D; Fordan S; Villaraza R; Crowe S; Gillis L
    J Clin Virol; 2013 Dec; 58 Suppl 1():e29-33. PubMed ID: 24342476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of turnaround time and total cost of HIV testing before and after implementation of the 2014 CDC/APHL Laboratory Testing Algorithm for diagnosis of HIV infection.
    Chen DJ; Yao JD
    J Clin Virol; 2017 Jun; 91():69-72. PubMed ID: 28461133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection and differentiation of HIV-2 using the point-of-care Alere q HIV-1/2 Detect nucleic acid test.
    Chang M; Steinmetzer K; Raugi DN; Smith RA; Ba S; Sall F; Seydi M; Niang A; Sall EI; Cisse O; Rödel K; Coombs RW; Gottlieb GS
    J Clin Virol; 2017 Dec; 97():22-25. PubMed ID: 29096389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative evaluation of the Bio-Rad Geenius HIV-1/2 Confirmatory Assay and the Bio-Rad Multispot HIV-1/2 Rapid Test as an alternative differentiation assay for CLSI M53 algorithm-I.
    Malloch L; Kadivar K; Putz J; Levett PN; Tang J; Hatchette TF; Kadkhoda K; Ng D; Ho J; Kim J
    J Clin Virol; 2013 Dec; 58 Suppl 1():e85-91. PubMed ID: 24342484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the performance of the Abbott ARCHITECT HIV Ag/Ab Combo Assay.
    Chavez P; Wesolowski L; Patel P; Delaney K; Owen SM
    J Clin Virol; 2011 Dec; 52 Suppl 1():S51-5. PubMed ID: 21983253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pooled nucleic acid testing increases the diagnostic yield of acute HIV infections in a high-risk population compared to 3rd and 4th generation HIV enzyme immunoassays.
    Krajden M; Cook D; Mak A; Chu K; Chahil N; Steinberg M; Rekart M; Gilbert M
    J Clin Virol; 2014 Sep; 61(1):132-7. PubMed ID: 25037533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of early HIV infections using the fourth generation Abbott ARCHITECT HIV Ag/Ab Combo chemiluminescent microparticle immunoassay (CIA) in San Diego County.
    Manlutac AL; Giesick JS; McVay PA
    J Clin Virol; 2013 Dec; 58 Suppl 1():e44-7. PubMed ID: 24342477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance of a fourth-generation HIV screening assay and an alternative HIV diagnostic testing algorithm.
    Nasrullah M; Wesolowski LG; Meyer WA; Owen SM; Masciotra S; Vorwald C; Becker WJ; Branson BM
    AIDS; 2013 Mar; 27(5):731-7. PubMed ID: 23135170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute infections, cost and time to reporting of HIV test results in three U.S. State Public Health Laboratories.
    Nasrullah M; Wesolowski LG; Ethridge SF; Cranston K; Pentella M; Myers RA; Rudrik JT; Hutchinson AB; Bennett SB; Werner BG
    J Infect; 2016 Aug; 73(2):164-72. PubMed ID: 27237366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the CDC proposed laboratory HIV testing algorithm among men who have sex with men (MSM) from five US metropolitan statistical areas using specimens collected in 2011.
    Masciotra S; Smith AJ; Youngpairoj AS; Sprinkle P; Miles I; Sionean C; Paz-Bailey G; Johnson JA; Owen SM
    J Clin Virol; 2013 Dec; 58 Suppl 1(Suppl 1):e8-e12. PubMed ID: 24342483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of an alternative HIV diagnostic algorithm using specimens from seroconversion panels and persons with established HIV infections.
    Masciotra S; McDougal JS; Feldman J; Sprinkle P; Wesolowski L; Owen SM
    J Clin Virol; 2011 Dec; 52 Suppl 1():S17-22. PubMed ID: 21981983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative performance of the Geenius™ HIV-1/HIV-2 supplemental test in Florida's public health testing population.
    Fordan S; Bennett B; Lee M; Crowe S
    J Clin Virol; 2017 Jun; 91():79-83. PubMed ID: 28434810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of an alternative supplemental testing strategy for HIV diagnosis by retrospective analysis of clinical HIV testing data.
    Styer LM; Sullivan TJ; Parker MM
    J Clin Virol; 2011 Dec; 52 Suppl 1():S35-40. PubMed ID: 22018662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Three Years of Shared Service HIV Nucleic Acid Testing for Public Health Laboratories: Worthwhile for HIV-1 but Not for HIV-2.
    Styer LM; Gaynor AM; Parker MM; Bennett SB; Wesolowski LG; Ethridge S; Chavez PR; Sullivan TJ; Fordan S; Wroblewski K
    Sex Transm Dis; 2020 May; 47(5S Suppl 1):S8-S12. PubMed ID: 31876868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of Xpert HIV-1 Qual assay for resolution of HIV-1 infection in samples with negative or indeterminate Geenius HIV-1/2 results.
    Michaeli M; Wax M; Gozlan Y; Rakovsky A; Mendelson E; Mor O
    J Clin Virol; 2016 Mar; 76():1-3. PubMed ID: 26761545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Qualitative Real-Time PCR Assay for HIV-1 and HIV-2 RNA.
    Yamazaki S; Kondo M; Sudo K; Ueda T; Fujiwara H; Hasegawa N; Kato S
    Jpn J Infect Dis; 2016 Sep; 69(5):367-72. PubMed ID: 26743143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.